连续收肌管阻滞中10 mL 0.15%与20 mL 0.25%布比卡因负荷量在全膝关节置换术中的比较:随机非劣效性试验
该随机非劣效性试验纳入140例行全膝关节置换术患者,比较连续收肌管阻滞中10 mL 0.15%与20 mL 0.25%布比卡因负荷量的镇痛效果。主要结局为术后6和12小时平均膝关节疼痛评分,非劣效界值为评分差1分。结果显示两组疼痛评分中位数差异均为0(95%CI -0.45至0.45),未超过非劣效界值,次要结局无临床差异。
要点
- 10 mL 0.15%布比卡因负荷量在术后6和12小时镇痛效果不劣于20 mL 0.25%负荷量。
- 两组疼痛评分中位数差异为0(95%CI -0.45至0.45),未超过非劣效界值1分。
- 次要结局包括静息和运动疼痛评分、吗啡用量及首次补救镇痛时间无临床差异。
核心结论
- 连续收肌管阻滞中10 mL 0.15%布比卡因负荷量在术后6和12小时提供的平均膝关节疼痛缓解与20 mL 0.25%负荷量相当。
研究设计与样本
- 随机非劣效性试验,纳入140例行全膝关节置换术患者,随机分为20 mL 0.25%布比卡因组或10 mL 0.15%布比卡因组。
- 两组均接受连续收肌管阻滞(0.15%布比卡因5 mL/小时)、局部浸润镇痛及腘动脉与膝关节囊间隙阻滞。
- 主要结局为术后6和12小时平均膝关节疼痛评分,非劣效界值为评分差1分。
主要发现
- 20/0.25组与10/0.15组术后6小时膝关节疼痛评分中位数分别为0(0至1)和0(0至2)。
- 20/0.25组与10/0.15组术后12小时膝关节疼痛评分中位数分别为2(1至2)和2(1至3)。
- 两个时间点中位治疗差异(10/0.15组减20/0.25组)均为0(95%CI -0.45至0.45),均未超过非劣效界值。
- 次要结局包括静息和运动疼痛评分、吗啡用量及首次补救镇痛时间未见临床差异。
关键数值与推荐
- 非劣效界值为疼痛评分差1分。
- 主要结局为术后6和12小时平均膝关节疼痛评分。
- 连续收肌管阻滞背景输注为0.15%布比卡因5 mL/小时。
临床怎么用
- 在包含连续收肌管阻滞、局部浸润镇痛及腘动脉与膝关节囊间隙阻滞的多模式镇痛方案中,可采用10 mL 0.15%布比卡因作为连续收肌管阻滞负荷量。
- 该较低浓度和容量方案在术后6和12小时镇痛效果不劣于20 mL 0.25%布比卡因负荷量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Different concentrations and volumes of local anesthetic boluses are used for continuous adductor canal block. We hypothesized that a 10 mL 0.15% bupivacaine bolus would provide non-inferior pain relief to a 20 mL 0.25% bupivacaine bolus for continuous adductor canal block as part of comprehensive multimodal analgesia. METHODS: 140 patients undergoing total knee arthroplasty were randomly allocated to receive either a 20 mL bolus of 0.25% bupivacaine (20/0.25 bupi group) or a 10 mL bolus of 0.15% bupivacaine (10/0.15 bupi group). Both groups received continuous adductor canal block with 0.15% bupivacaine (5 mL/hour), local infiltration analgesia, and interspace between the popliteal artery and capsule of the knee block. The primary outcomes were average knee-pain scores 6 and 12 hours postoperatively; the non-inferiority margin was a score difference of 1. Secondary outcomes included rest and movement pain scores, morphine consumption, and time to first rescue analgesia. RESULTS: The median knee-pain scores for the 20/0.25 and 10/0.15 bupi groups were 0 (0 to 1) and 0 (0 to 2), respectively, after 6 hours and 2 (1 to 2) and 2 (1 to 3), respectively, after 12 hours. The median treatment difference (10/0.15 bupi ̶ 20/0.25 bupi) was 0 (95% CI -0.45 to 0.45) at both time points, with neither interval exceeding the non-inferiority margin. No clinical differences were observed in secondary outcomes. DISCUSSION: A 10 mL 0.15% bupivacaine bolus in continuous adductor canal block offers comparable average knee-pain relief 6 and 12 hours after total knee arthroplasty to a 20 mL 0.25% bupivacaine bolus. TRIAL REGISTRATION NUMBER: NCT06179628.
引用
- Kampitak W, Tanavalee A, Ngarmukos S, et al. Comparison of 10 mL 0.15% vs 20 mL 0.25% bupivacaine boluses for continuous adductor canal block in total knee arthroplasty: a randomized non-inferiority trial. Reg Anesth Pain Med. 2025. PMID: 40393775. doi:10.1136/rapm-2025-106587
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。